G.P.110 : Safety and pharmacokinetic profile of eteplirsen, SRP-4045, and SRP-4053, three phosphorodiamidate morpholino oligomers (PMOs) for the treatment of patients with Duchenne muscular dystrophy (DMD)
| Autor: | Sazani, P., Magee, T., Charleston, J.S., Shanks, C., Zhang, J., Carver, M., Rodino-Klapac, L., Sahenk, Z., Roush, K., Bird, L., Lowes, L.P., Alfano, L., Gomez, A.M., Lewis, S., Malik, V., Shontz, K., Flanigan, K., Shilling, C., Bhalli, J., Kaur, H., Walisser, J., Forget, J., Saoud, J., Mendell, J.R., Kaye, E. |
|---|---|
| Zdroj: | In Neuromuscular Disorders October 2014 24(9-10):828-828 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect